Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 13.69
-0.55 (-3.86%)
Apr 9, 2026, 3:04 PM CST
SHE:002923 Market Cap
SHE:002923 has a market cap or net worth of 4.77 billion as of April 9, 2026. Its market cap has increased by 33.71% in one year.
Market Cap
4.77B
Enterprise Value
5.11B
Revenue
1.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
13.69
Market Cap Chart
Since January 5, 2018, SHE:002923's market cap has increased from 2.45B to 4.77B, an increase of 94.73%. That is a compound annual growth rate of 8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 4.58B | 12.67% |
| Dec 31, 2025 | 4.07B | 27.36% |
| Dec 31, 2024 | 3.19B | -22.69% |
| Dec 29, 2023 | 4.13B | -1.28% |
| Dec 30, 2022 | 4.19B | -8.03% |
| Dec 31, 2021 | 4.55B | 51.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Biocause Heilen Pharmaceutical | 5.12B |
| Fuan Pharmaceutical (Group) | 5.09B |
| Jinling Pharmaceutical Company | 5.04B |
| Bide Pharmatech | 5.01B |
| Tibet Duo Rui Pharmaceutical | 4.92B |
| Newland Pharmaceutical | 4.80B |
| Hunan Fangsheng Pharmaceutical | 4.79B |
| Shandong Sinobioway Biomedicine | 4.74B |